The Tel Aviv District Court approved the certification of a class action lawsuit against IceCure Medical Ltd., its officers, and directors, alleging that a March 2021 private placement was conducted at a significant discount and involved defective approval processes. The Company intends to defend itself vigorously and plans to file a motion for reconsideration by July 5, 2026, while seeking a stay of proceedings through mediation. IceCure Medical Ltd. is a medical technology company specializing in in-body cryoablation technology.
